Levacetylmethadol
From Wikipedia, the free encyclopedia
 |
|
|
Levacetylmethadol
|
|
| Systematic (IUPAC) name | |
| [(3S,6S)-4,4-dicyclohexyl-6-dimethylaminoheptan-3-yl] acetate | |
| Identifiers | |
| CAS number | 43033-72-3 (hydrochloride) |
| ATC code | N07 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C23H31NO2 |
| Mol. mass | 353.498 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Levacetylmethadol (INN, or methadyl acetate) is a drug used in treating opioid addiction. It is structurally related to methadone.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||
